We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

209 hedge funds and large institutions have $1.07B invested in Supernus Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 80 increasing their positions, 71 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 71

1.41% more ownership

Funds ownership: 96.21% → 97.62% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 218 → 209 (-9)

11% less capital invested

Capital invested by funds: $1.2B → $1.07B (-$129M)

29% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 31

65% less call options, than puts

Call options by funds: $595K | Put options by funds: $1.71M

Holders
209
Holders Change
-9
Holders Change %
-4.13%
% of All Funds
4.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
80
Reduced
71
Closed
31
Calls
$595K
Puts
$1.71M
Net Calls
-$1.12M
Net Calls Change
-$1.97M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$22.5M
2
Victory Capital Management
Victory Capital Management
Texas
+$10.4M
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.26M
4
GKIM
GW&K Investment Management
Massachusetts
+$5.88M
5
BGIM
Brandywine Global Investment Management
Pennsylvania
+$5.1M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$7M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.76M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5.75M
4
Morgan Stanley
Morgan Stanley
New York
-$4.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$4.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
201
Quadrant Capital Group
Ohio
$2K – – –
TWA
202
TCI Wealth Advisors
Arizona
$2K – – –
ACM
203
AUA Capital Management
Pennsylvania
$2K +$1.73K +76 New
NFG
204
Next Financial Group
Texas
$2K +$2.27K +100 New
FP
205
Financial Perspectives
Minnesota
$1.08K – – –
PFBT
206
Parkside Financial Bank & Trust
Missouri
$1K -$363 -16 -36%
AF
207
Allworth Financial
California
$1K – – –
CAW
208
Cornerstone Advisors (Washington)
Washington
$1K +$272 +12 +50%
Millennium Management
209
Millennium Management
New York
$225 -$440K -19,406 -64%
Two Sigma Investments
210
Two Sigma Investments
New York
– -$7M -294,948 Closed
BFM
211
Boothbay Fund Management
New York
– -$3.61M -151,900 Closed
First Manhattan
212
First Manhattan
New York
– -$2.23M -93,770 Closed
CSS
213
Cubist Systematic Strategies
Connecticut
– -$1.48M -62,091 Closed
HighTower Advisors
214
HighTower Advisors
Illinois
– -$1.22M -51,379 Closed
USGIU
215
U.S. Global Investors (USGI)
Texas
– -$701K -29,514 Closed
QIM
216
Quantitative Investment Management
Virginia
– -$559K -23,554 Closed
WAM
217
Wakefield Asset Management
Colorado
– -$518K -21,831 Closed
BWFA
218
Baltimore-Washington Financial Advisors
Maryland
– -$486K -20,502 Closed
Balyasny Asset Management
219
Balyasny Asset Management
Illinois
– -$439K -18,475 Closed
ZCM
220
Zebra Capital Management
Connecticut
– -$438K -18,446 Closed
HF
221
HRT Financial
New York
– -$339K -14,282 Closed
SFM
222
Systematic Financial Management
New Jersey
– -$335K -14,110 Closed
CIM
223
CIM Investment Management
Pennsylvania
– -$332K -13,985 Closed
Truist Financial
224
Truist Financial
North Carolina
– -$329K -13,845 Closed
PTC
225
Petrus Trust Company
Texas
– -$282K -11,876 Closed
6 7 8
9
10

SUPN Hedge Fund Activity: Q3 2020 in Review

209 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q3 2020, worth a combined $1.07B — down 11% from $1.2B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SUPN and 22 opened new positions — a net loss of 9 holders — while 71 trimmed existing stakes and 80 added.

The largest buyer was Armistice Capital, adding an estimated $22.5M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $7M sold.

  • 209 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q3 2020, down from 218 in Q2 2020.
  • Funds reported $1.07B of Supernus Pharmaceuticals stock for Q3 2020, down 11% quarter-over-quarter.
  • 22 funds opened new Supernus Pharmaceuticals positions in Q3 2020 and 31 closed out, a net change of -9 holders.
  • The largest Supernus Pharmaceuticals buyer in Q3 2020 was Armistice Capital, an estimated $22.5M added.
  • The largest Supernus Pharmaceuticals seller in Q3 2020 was Two Sigma Investments, an estimated $7M sold.

Based on aggregated 13F filings for Q3 2020.